After Animals uncovers trends and stories at the cutting edge of the global post-animal movement. What does a future look like, in which food, fashion and entertainment no longer have to exploit animals to be successful? In each episode, we share a remarkable and inspiring story about someone who is forging a more compassionate future for us all. After Animals seeks to activate a kinder, more compassionate world through innovation.
Lab-Made Human Hearts to End Animal Testing? This Tiny Technology Has Huge Potential - TARA Biosystems' Misti Ushio
TARA Biosystems has raised $21.3 million to date and is the world’s only company that generates human cardiac tissue—outside of the human body. Instead of testing on animals, researchers will be able to test drugs right on actual human tissue and the industry will be able to save time, money and unnecessary animal suffering throughout the drug development process.
In this episode, we feature an eye-opening interview with TARA Biosystems’ CEO Misti Ushio, to learn more about how their breakthrough technology came to be, how it works, the enormous potential it holds, as well as some of the challenges that still need to be overcome for it and other similar technologies to be used widely in the “real world.” In the episode intro, Sharanya and Ulara share some key stats and figures from the animal testing alternatives landscape, and discuss some of the surprisingly major players already involved in the emerging space, including government leaders and regulatory agencies.
TARA Biosystems’ website: https://tarabiosystems.com/
The article we refer to in the episode is “The next phase of drug creation: Why animal models are on the brink of extinction” via Pharma Manufacturing: https://www.pharmamanufacturing.com/articles/2021/the-next-phase-of-drug-creation/
Support the show (https://www.afteranimals.com/support-us)
Replay: This Lab-Grown Shrimp Startup is Blowing Up. Here’s Why - Shiok Meats’ Sandhya Sriram
In this episode, we revisit our Season 1 conversation with Dr. Sandhya Sriram, CEO and Co-Founder of cultured seafood maker Shiok Meats. In December 2020, Singapore became the first country to approve cultured cell-based meat for human consumption. So for this replay, we’ve included a special segment to discuss how diners are reacting to trying cultured meat (chicken) in the real world, for the first time! We then go back to our original episode in which we talk with Dr. Sriram about how her fast-rising startup initially raised $4.6 million in funding AND created an MVP (minimum viable product)… in under a year. Now, that funding has hit over $20 million, and Shiok Meats is poised to become the first cultured cell-based crustacean meat company to have their products widely available in the market by 2022. Dr. Sandhya Sriram takes us into the fascinating world of lab-grown shrimp, crab and lobster, and also shares some valuable tips and insights for rising entrepreneurs in the space.
Shiok Meats website: https://shiokmeats.com/
Music interlude created by Lee Rosevere.
Support the show (https://www.afteranimals.com/support-us)
This Startup is Making the World's First Bee-Less Honey... and Saving the Bees - MeliBio's Darko Mandich
California-based startup MeliBio is creating real honey that replicates AND actually improves upon bee-made honey—without ever exploiting or harming bees. In this eye-opening episode, CEO Darko Mandich tells us how MeliBio is creating vegan, bee-less honey that is based on the molecular composition of commercially available honey. MeliBio also plans to take their honey a step further and customize it to be better than the bee-made version. Darko also shares with us why it's so important we work to stop the destruction of our planet's bee population by creating alternatives that consumers can turn to. Honey is one of the most powerful super-ingredients ever to exist in nature, but commercial production is damaging to bees and their ecosystems. If Earth's 20,000 wild and native bee species died, the surface of our lush planet would quickly turn barren and look more like Mars. MeliBio's website: https://www.melibio.com/
Can Robot Dolphins + VR Elephants Help End Zoos and Aquariums? - Edge Innovations' Roger Holzberg and Wild Immersion's Adrien Moisson
Let's face it. Zoos and aquariums suck for animals. In this episode, we hear from two companies that are creating encounters with wildlife without ever harming or disturbing animals. Some of their top projects include life-size realistic animatronic dolphins who can communicate with us and 3D cameras that enable us to see the world through the eyes of an elephant on the African savannah. In this episode, Roger Holzberg of Edge Innovations and Adrien Moisson of Wild Immersion tell us how their companies are using cutting-edge technologies to reinvent and reshape the wildlife display and marine park industry worldwide. This is the After Animals podcast's first-ever double feature!
Animal Testing Will End in our Lifetimes. Here's How - Center for Contemporary Sciences' Dr. Aysha Akhtar
The National Institutes of Health (NIH) has noted that a staggering 95% of all drugs shown to be safe and effective in animal tests FAIL in human trials because they don't work or are dangerous. This is just one sobering data point from a growing body of evidence that animal-based research doesn't translate to human health. Dr. Aysha Akhtar is the CEO and President of the Center for Contemporary Sciences. She and her team at CCS are working to accelerate the industry's shift towards more innovative, reliable, and promising scientific testing methods that draw from human biology vs. animals. In this episode, she explains why we can end unreliable and cruel animal testing within our lifetimes... and replace it with something far better for the future of human health. It's an eye-opening and hopeful interview, filled with facts, data, and anecdotes on an important topic. Center For Contemporary Sciences' website: https://www.contemporarysciences.org/
Baby Formula 2.0: Is Lab-Grown Breastmilk the Next Parenting Trend? - TurtleTree Labs' Fengru Lin & Max Rye
TurtleTree Labs—a Singapore-based startup—has set its sights on disrupting the baby formula industry, which is projected to grow to US$103 Billion by 2026. Co-founders Fengru Lin and Max Rye explain how they are using donated human stem cells to create mammary cells in the lab that lactate real human breast milk! Their first-of-its-kind biotech approach is getting a lot of support—from investors and from the Singaporean government—and the company believes it could be in the market within the next year. Once they perfect human breast milk, they plan to expand their sustainable, contaminant-free milk production methods to encompass other mammalian species including cows.
This podcast not only highlights topics that uncover and identify our shared humanity, it seeks to spark the imagination and intention for a better future.
Every episode makes me feel closer to the heart of life and keeps me inspired by how far we’ve come — but no longer ignorant about the work it takes to keep moving in the right direction.
I really like her passion for the subject.